Kyung-Hee Kim Selected Research

Brain Natriuretic Peptide (Natrecor)

6/2013	ULTIMATE-SHF trial (UdenafiL Therapy to Improve symptoMAtology, exercise Tolerance and hEmodynamics in patients with chronic systolic heart failure): study protocol for a randomized, placebo-controlled, double-blind trial.
6/2013	Change of B-type natriuretic peptide after surgery and its association with rhythm status in patients with chronic severe mitral regurgitation.
1/2013	Prognostic value of B-type natriuretic peptide in patients with chronic mitral regurgitation undergoing surgery: mid-term follow-up results.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyung-Hee Kim Research Topics

Disease

45	Neoplasms (Cancer) 01/2022 - 02/2003
11	Colonic Neoplasms (Colon Cancer) 05/2017 - 06/2012
11	Colorectal Neoplasms (Colorectal Cancer) 04/2016 - 09/2006
6	Carcinoma (Carcinomatosis) 05/2022 - 12/2006
6	Inflammation (Inflammations) 01/2020 - 01/2013
6	Adenocarcinoma 12/2019 - 03/2011
6	Renal Cell Carcinoma (Grawitz Tumor) 10/2019 - 06/2011
6	Fibrosis (Cirrhosis) 01/2019 - 04/2010
6	Carcinogenesis 02/2018 - 09/2003
5	Rectal Neoplasms (Rectal Cancer) 01/2022 - 06/2012
5	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2003
5	Ovarian Neoplasms (Ovarian Cancer) 07/2018 - 09/2002
4	Heart Failure 11/2022 - 06/2013
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 03/2011
4	Myocardial Infarction 01/2021 - 09/2010
4	Hepatocellular Carcinoma (Hepatoma) 10/2019 - 12/2018
4	Lung Neoplasms (Lung Cancer) 08/2019 - 11/2006
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 11/2006
4	Adenoma (Adenomas) 02/2018 - 12/2006
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 04/2012
3	Virus Diseases (Viral Diseases) 12/2021 - 12/2017
3	Gastritis 12/2021 - 01/2016
3	Infections 09/2019 - 12/2017
3	Adenocarcinoma of Lung 08/2019 - 03/2011
3	Breast Neoplasms (Breast Cancer) 01/2019 - 10/2008
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 02/2013
3	Parkinson Disease (Parkinson's Disease) 04/2015 - 09/2011
3	Mitral Valve Insufficiency (Mitral Regurgitation) 06/2013 - 03/2012
2	Liver Cirrhosis (Hepatic Cirrhosis) 03/2022 - 01/2019
2	Medulloblastoma 12/2021 - 09/2020
2	Hemorrhage 07/2021 - 06/2011
2	Ventricular Remodeling 04/2021 - 03/2012
2	Metabolic Diseases (Metabolic Disease) 01/2021 - 01/2021
2	Cholangiocarcinoma 08/2019 - 12/2017
2	Atrial Fibrillation 06/2019 - 06/2018
2	Anaplastic Thyroid Carcinoma 01/2019 - 11/2016
2	Hearing Loss (Hearing Impairment) 01/2019 - 01/2018
2	Ototoxicity 01/2019 - 01/2018
2	Lymphatic Metastasis 02/2018 - 04/2014
2	Polyps 01/2017 - 12/2016
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2014 - 01/2008
2	Renal Insufficiency (Renal Failure) 01/2014 - 01/2012
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2012 - 10/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2012 - 03/2011
2	Body Weight (Weight, Body) 02/2011 - 09/2003
2	Thyroid Neoplasms (Thyroid Cancer) 01/2007 - 12/2006

Drug/Important Bio-Agent (IBA)

34	Proteins (Proteins, Gene)FDA Link 05/2022 - 09/2002
13	Biomarkers (Surrogate Marker)IBA 05/2022 - 09/2003
6	Pharmaceutical PreparationsIBA 01/2021 - 06/2010
6	EnzymesIBA 08/2019 - 06/2012
5	Biological ProductsIBA 05/2022 - 01/2007
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2007
5	Fluorouracil (Carac)FDA LinkGeneric 03/2014 - 06/2012
4	Protein Kinases (Protein Kinase)IBA 01/2020 - 01/2017
4	Messenger RNA (mRNA)IBA 01/2020 - 01/2008
4	Therapeutic UsesIBA 01/2019 - 09/2012
4	Protein Glutamine gamma Glutamyltransferase 2IBA 11/2018 - 01/2013
3	IonsIBA 12/2021 - 03/2014
3	AntioxidantsIBA 01/2019 - 09/2011
3	ProteomeIBA 01/2019 - 10/2008
3	udenafilIBA 09/2015 - 06/2013
3	Phosphodiesterase 5 InhibitorsIBA 09/2015 - 06/2013
3	CateninsIBA 07/2015 - 01/2012
3	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2013 - 01/2013
3	ErbB Receptors (EGF Receptor)IBA 01/2012 - 03/2011
2	RNA (Ribonucleic Acid)IBA 05/2022 - 01/2022
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2022 - 01/2019
2	CXC ChemokinesIBA 01/2022 - 12/2018
2	InterferonsIBA 12/2021 - 12/2017
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2021 - 01/2016
2	Acetic Acid (Vinegar)FDA LinkGeneric 09/2020 - 01/2016
2	protein kinase C zetaIBA 08/2019 - 01/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 02/2011
2	Estrogens (Estrogen)FDA Link 01/2019 - 09/2016
2	BR101549IBA 01/2019 - 01/2019
2	sodium-iodide symporter (sodium iodide symporter)IBA 01/2019 - 11/2016
2	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 12/2017 - 08/2014
2	Calgranulin BIBA 01/2017 - 04/2016
2	Peptides (Polypeptides)IBA 05/2016 - 11/2006
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 09/2015 - 06/2013
2	GadoliniumIBA 06/2015 - 07/2012
2	Imatinib Mesylate (Gleevec)FDA Link 05/2014 - 01/2008
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2013 - 07/2011
2	IronIBA 01/2013 - 04/2010
2	BromidesIBA 09/2012 - 06/2012
2	Rituximab (Mabthera)FDA Link 05/2012 - 10/2011
2	Fatty Acids (Saturated Fatty Acids)IBA 02/2011 - 09/2003
1	Neprilysin (Neutral Endopeptidase)IBA 11/2022
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2022
1	Class 2 Receptor-Like Protein Tyrosine PhosphatasesIBA 05/2022

Therapy/Procedure

22	Therapeutics 11/2022 - 01/2007
5	Drug Therapy (Chemotherapy) 04/2015 - 02/2003
4	Chemoradiotherapy 01/2016 - 06/2012
3	Wearable Electronic Devices 01/2021 - 10/2020
2	Precision Medicine 09/2020 - 01/2018
2	Lasers (Laser) 07/2018 - 01/2016
2	Radiotherapy 03/2014 - 12/2012
2	Stents 01/2012 - 06/2011
2	Drug-Eluting Stents 01/2012 - 06/2011